Categories | Sensitivity (CI 95%) | Specificity (CI 95%) | NPV (CI 95%) | PPV (CI 95%) | Accuracy (CI 95%) |
---|---|---|---|---|---|
Tuberculous pleurisy | |||||
Lymphocyte ≥ 50% | 0.755 (0.708–0.797) | 0.887 (0.862–0.908) | 0.880 (0.855–0.902) | 0.767 (0.720–0.809) | 0.843 (0.821–0.864) |
Lymphocyte ≥ 35% | 0.885 (0.849–0.916) | 0.823 (0.794–0.850) | 0.936 (0.914–0.953) | 0.712 (0.669–0.753) | 0.843 (0.821–0.865) |
LD/ADA < 18 | 0.917 (0.885–0.943) | 0.801 (0.771–0.829) | 0.951 (0.932–0.967) | 0.695 (0.652–0.735) | 0.840 (0.817–0.860) |
Lymphocyte ≥ 35% and LD/ADA < 18 | 0.837 (0.796–0.873) | 0.926 (0.905–0.944) | 0.920 (0.899–0.938) | 0.849 (0.808–0.884) | 0.897 (0.878–0.914) |
Lymphocyte ≥ 35% and LD/ADA < 18 and ADA < 150 | 0.824 (0.782–0.861) | 0.937 (0.917–0.953) | 0.915 (0.893–0.934) | 0.866 (0.826–0.899) | 0.900 (0.880–0.916) |
Hematologic MPE in pleural effusion with ADA ≥ 150 | |||||
PMN < 50% | 0.913 (0.720–0.989) | 0.850 (0.765–0.914) | 0.977 (0.919–0.997) | 0.583 (0.408–0.745) | 0.862 (0.788–0.917) |
PMN < 50% and serum LD ≥ 2× serum ULN | 0.870 (0.664–0.972) | 0.857 (0.753–0.929) | 0.952 (0.867–0.990) | 0.667 (0.472–0.827) | 0.860 (0.822–0.941) |